Seeking Alpha

Shares of Vanda Pharmaceutical (VNDA -11.8%) take a hit in early trading after announcing...

Shares of Vanda Pharmaceutical (VNDA -11.8%) take a hit in early trading after announcing earlier that it's depression disorder treatment tasimelteon had failed to meet its endpoint in Phase IIb/III trials.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|